OneMedNet Corporation (NASDAQ: ONMD) shares skyrocketed over 168% on Monday after the company announced participation as an exhibitor at the 15ᵗʰ Annual SCOPE Summit.
OneMedNet Corporation (ONMD) has confirmed its presence as an exhibitor at the forthcoming 15th Annual SCOPE Summit for Clinical Ops Executives. The summit has been scheduled for February 11 to 14, 2024, in Orlando, FL.
According to the official press release, OneMedNet’s top leaders, including Founder and Chief Medical Officer Jeffrey Yu, President Aaron Green, and other senior team members, will be at Booth 228 to discuss the company’s groundbreaking iRWDTM solution. This will take place in the Real-World Evidence track of the SCOPE Summit.
The 2024 SCOPE Summit will feature two Real World Evidence tracks, shedding light on the crucial role and cutting-edge advancements in specialized data. The focus areas include Accessing and Generating RWD and Leveraging RWD for Clinical Research and Observational Research.
OneMedNet is persistently extending its reach to more healthcare systems and providers. Simultaneously, the company is making its specialized Real-World Data (RWD), equipped with proprietary Artificial Intelligence (AI) tools, more accessible to the broader life sciences market through mainstream online data marketplaces.
The SCOPE Summit is an annual event recognized for its profound impact on the industry. It brings together clinical trial operations executives actively seeking new technologies to improve the experience for patients, sites, and study teams.
OneMedNet (NASDAQ: ONMD) Stock Price Action
ONMD stock shot up 168.21% on Monday. The traders had exchanged hands with 76,905,943 (76.90 million) shares compared to the average daily trading volume of 125.89 thousand.
